biostudies-literatureUnknown14(7)Auclin Ethe Contrato Juan Rodes 2020Ayuda de la Acción Estratégica en Salud-ISCIII FIS 2021Ayuda SEOM-Juan Rodés 2020Translational Lung Cancer Research2427-2436https://www.ebi.ac.uk/biostudies/studies/S-EPMC12337063biostudies-literatureUpfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort—the smile studyPMC12337063JR20/00019PI21/01653Di Federico AMinatta JAboubakar FDe Giglio ATagliamento MSacco GGerber HGirard NAlbarran-Artahona VEpaillard NDu Rusquec PMoran-Bueno TBerthou HRecondo GGorria TJimenez-Munarriz BMezquita LBlaquier JLopez-Castro RBesse BLaguna JAuclin EfalseUpfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort—the smile study2025-01-01T00:00:00Z2025 Jul2026-05-29T17:23:17.417Z2026-04-08T05:36:50.367ZS-EPMC12337063